We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Editorial Commentary: Understanding Risk and Enhancing Safety in Immunotherapy Trials.
- Authors
Kumar, Deepali; Humar, Atul
- Abstract
The authors reflect on a study based on the development of novel immunosuppressive therapies. They discuss the advancement in the clinical applications of these therapies which is capable in preventing alloimmunity and autoimmunity. They also mention several viruses that could affect the immunotherapy trials including Epstein-Barr virus(EBV), cytomegalovirus (CMV) and herpes simplex virus (HSV).
- Publication
Clinical Infectious Diseases, 2013, Vol 56, Issue 2, p255
- ISSN
1058-4838
- Publication type
Academic Journal
- DOI
10.1093/cid/cis855